Journey Medical Corporation

Informe acción NasdaqCM:DERM

Capitalización de mercado: US$108.6m

Salud financiera de hoja de balance de Journey Medical

Salud financiera controles de criterios 3/6

Journey Medical tiene un patrimonio de los accionistas total de $10.9M y una deuda total de $21.0M, lo que sitúa su ratio deuda-patrimonio en 192.5%. Sus activos y pasivos totales son $64.0M y $53.1M respectivamente.

Información clave

192.5%

Ratio deuda-patrimonio

US$21.04m

Deuda

Ratio de cobertura de interesesn/a
EfectivoUS$22.46m
PatrimonioUS$10.93m
Total pasivoUS$53.12m
Activos totalesUS$64.04m

Actualizaciones recientes sobre salud financiera

Here's Why Journey Medical (NASDAQ:DERM) Has A Meaningful Debt Burden

Sep 14
Here's Why Journey Medical (NASDAQ:DERM) Has A Meaningful Debt Burden

Does Journey Medical (NASDAQ:DERM) Have A Healthy Balance Sheet?

May 06
Does Journey Medical (NASDAQ:DERM) Have A Healthy Balance Sheet?

Recent updates

Journey Medical Corporation (NASDAQ:DERM) Shares Fly 31% But Investors Aren't Buying For Growth

Oct 03
Journey Medical Corporation (NASDAQ:DERM) Shares Fly 31% But Investors Aren't Buying For Growth

Here's Why Journey Medical (NASDAQ:DERM) Has A Meaningful Debt Burden

Sep 14
Here's Why Journey Medical (NASDAQ:DERM) Has A Meaningful Debt Burden

Does Journey Medical (NASDAQ:DERM) Have A Healthy Balance Sheet?

May 06
Does Journey Medical (NASDAQ:DERM) Have A Healthy Balance Sheet?

Journey Medical Corporation (NASDAQ:DERM) Not Doing Enough For Some Investors As Its Shares Slump 31%

Mar 11
Journey Medical Corporation (NASDAQ:DERM) Not Doing Enough For Some Investors As Its Shares Slump 31%

Journey Medical Corporation's (NASDAQ:DERM) 33% Dip In Price Shows Sentiment Is Matching Revenues

Jan 18
Journey Medical Corporation's (NASDAQ:DERM) 33% Dip In Price Shows Sentiment Is Matching Revenues

Journey Medical Corporation's (NASDAQ:DERM) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Nov 10
Journey Medical Corporation's (NASDAQ:DERM) Price Is Right But Growth Is Lacking After Shares Rocket 26%

US$12.00: That's What Analysts Think Journey Medical Corporation (NASDAQ:DERM) Is Worth After Its Latest Results

May 12
US$12.00: That's What Analysts Think Journey Medical Corporation (NASDAQ:DERM) Is Worth After Its Latest Results

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo ($46.2M) de DERM superan a sus pasivos a corto plazo ($33.3M).

Pasivo a largo plazo: Los activos a corto plazo de DERM ($46.2M) superan a sus pasivos a largo plazo ($19.8M).


Historial y análisis de deuda-patrimonio

Nivel de deuda: DERM tiene más efectivo que su deuda total.

Reducción de la deuda: No se dispone de datos suficientes para determinar si el ratio deuda-patrimonio de DERM se ha reducido en los últimos 5 años.


Hoja de balance


Análisis de cash runway

En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.

Cash runway estable: DERM tiene menos de un año de cash runway basado en su flujo de caja libre actual.

Pronóstico de cash runway: DERM tiene menos de un año de cash runway si el flujo de caja libre sigue reduciéndose a tasas históricas de 19.9% cada año


Descubre empresas con salud financiera